Today: 23 January 2026
Subscribe
Browse Category

NASDAQ:CRSP News 23 January 2026

CRISPR Therapeutics stock in focus as shares cool premarket after 11% surge and CEO sale filing

CRISPR Therapeutics stock in focus as shares cool premarket after 11% surge and CEO sale filing

New York, Jan 23, 2026, 05:47 (EST) — Premarket CRISPR Therapeutics AG shares slipped about 0.5% to $60.51 in premarket trading on Friday, following a sharp 11.1% gain the previous day. The stock closed at $60.81 on Thursday after hitting an intraday high of $60.86 and seeing over 3.4 million shares change hands. Investors were reacting to an insider-sale filing.…
23 January 2026
····

Stock Market Today

  • UnitedHealth Group Stock Forecast 2026-2030: Analyst Price Targets and Market Outlook
    January 23, 2026, 9:41 AM EST. UnitedHealth Group (UNH) trades near $339 on Jan 16, 2026, ahead of its full-year 2025 results and 2026 guidance due Jan 27. Analyst consensus from Barchart, Benzinga, MarketWatch and Investing.com points to 12-month price targets averaging around $390-$395, implying 15-17% upside. Projections reflect optimism around improving Medicare Advantage profits, margin recovery and earnings growth, tempered by regulatory and reimbursement uncertainties. MarketWatch tags an 'overweight' average rating on UnitedHealth shares. The outlook anchors on evolving reimbursement trends and utilization patterns impacting earnings forecasts. Investors watch upcoming earnings guidance to gauge if growth trajectories sustain in the face of potential policy shifts.
Go toTop